PCN54 EFFICACY AND SAFETY OF MOGAMULIZUMAB IN PREVIOUSLY TREATED, ADVANCED STAGE MYCOSIS FUNGOIDES AND SÉZARY SYNDROME PATIENTS: A POST-HOC ANALYSIS OF THE MAVORIC STUDY

Subjects

Subjects :

medicine.medical_specialty
Mycosis fungoides
business.industry
Health Policy
Advanced stage
Public Health, Environmental and Occupational Health
medicine.disease
Dermatology
Post-hoc analysis
medicine
Mogamulizumab
business
Previously treated
medicine.drug

Details

ISSN :

10983015

Volume :

22

Database :

OpenAIRE

Journal :

Value in Health

Accession number :

edsair.doi...........3f3ca71488a3501dcaa033efae73b118

Full Text :

https://doi.org/10.1016/j.jval.2019.09.251